Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
15.46
-0.05 (-0.32%)
At close: Jul 2, 2024, 4:00 PM
15.45
-0.01 (-0.06%)
After-hours: Jul 2, 2024, 7:20 PM EDT
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $1.17 billion as of July 2, 2024. Its market cap has decreased by -31.65% in one year.
Market Cap
1.17B
Enterprise Value
965.05M
1-Year Change
-31.65%
Ranking
Category
Stock Price
$15.46
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $173.40M to $1.17B, an increase of 573.97%. That is a compound annual growth rate of 30.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.26B | -20.87% |
| Dec 29, 2023 | 1.59B | -19.57% |
| Dec 30, 2022 | 1.98B | 389.96% |
| Dec 31, 2021 | 403.30M | 33.68% |
| Dec 31, 2020 | 301.70M | 298.55% |
| Dec 31, 2019 | 75.70M | -40.25% |
| Dec 31, 2018 | 126.70M | -16.92% |
| Dec 29, 2017 | 152.50M | -12.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 1.21B |
| Day One Biopharmaceuticals | 1.20B |
| Immatics | 1.20B |
| Spyre Therapeutics | 1.19B |
| Xencor | 1.17B |
| Prothena Corporation | 1.11B |
| AtriCure | 1.10B |
| Enliven Therapeutics | 1.10B |